EXTON,
Pa., Dec. 11, 2024 /PRNewswire/ -- West
Pharmaceutical Services, Inc. (NYSE: WST), a global leader in
innovative solutions for injectable drug administration, today
announced the Company's Board of Directors has elected Janet
Haugen as its newest member. With the addition of Ms. Haugen,
West's Board has 12 directors.
Ms. Haugen, 66, is the former Chief Financial Officer of Unisys
Corporation, a role she served in for more than 16 years. During
her 20-year tenure at Unisys, Ms. Haugen oversaw the business
transformation from a mainframe hardware, software and maintenance
company to an IT services and software provider. In addition to her
core finance responsibilities, she had oversight of Unisys'
corporate development, IT, procurement, facilities and legal
functions.
Prior to joining Unisys, Ms. Haugen was a partner at Ernst &
Young working with Fortune 500 companies serving global clients in
the technology and manufacturing industries.
Ms. Haugen currently serves on the Board of Directors of Bentley
Systems, Juniper Networks and CentralSquare Technologies.
Ms. Haugen earned her degree in Economics from Rutgers University. In addition, she is a certified
director of the National Association of Corporate Directors
(NACD).
"We are pleased to welcome Janet
Haugen to West's Board of Directors," said Paolo Pucci, Lead Independent Director, West.
"Janet's unique combination of technology and finance expertise
makes her an invaluable addition to our Board of Directors. With
her significant board experience and proven operational track
record, Janet will help us continue to enhance the impact of West's
role to deliver healthcare to millions of patients every day."
About West
West Pharmaceutical Services, Inc. is a leading provider of
innovative, high-quality injectable solutions and services. As a
trusted partner to established and emerging drug developers, West
helps ensure the safe, effective containment and delivery of
life-saving and life-enhancing medicines for patients. With 10,000
team members across 50 sites worldwide, West helps support our
customers by delivering approximately 43 billion components and
devices each year.
Headquartered in Exton,
Pennsylvania, West in its fiscal year 2023 generated
$2.95 billion in net sales. West is
traded on the New York Stock Exchange (NYSE: WST) and is included
on the Standard & Poor's 500 index. For more information, visit
www.westpharma.com.
All trademarks and registered trademarks used in this release
are the property of West Pharmaceutical Services, Inc. or its
subsidiaries, in the United States and other jurisdictions, unless
otherwise noted.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/west-elects-new-director-to-the-board-302328461.html
SOURCE West Pharmaceutical Services, Inc.
